Development of Intravitreal Vector Delivery Modality for Gene Therapy as a New Standard of Care for Ocular Diseases

Time: 2:15 pm
day: Day Two


  • Intravitreal delivery of gene therapy for the treatment of highly prevalent ocular diseases and inherited retinal diseases, its advantages, and challenges
  • Proof of concept studies provide strong support of IVT gene therapy as efficacious and well tolerated modality for treatment of ocular diseases
  • Challenges of translating ocular gene therapy from nonclinical data into clinic